Shi; Wei-Xing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shi; Wei-Xing.The latest application filed is for "preparation of inactivated artificial antigen presenting cells and their use in cell therapies".

Company Profile

0.15.16

Shi; Wei-Xing - San Diego CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies Grant 8,357,533 - Cai , et al. January 22, 2	2013-01-22
Identification of antigenic peptides from multiple myeloma cells Grant 8,323,965 - Cai , et al. December 4, 2	2012-12-04
Identification of antigenic peptides from multiple myeloma cells Grant 8,323,655 - Cai , et al. December 4, 2	2012-12-04
Identification of antigenic peptides from multiple myeloma cells Grant 8,232,101 - Cai , et al. July 31, 2	2012-07-31
Preparation Of Inactivated Artificial Antigen Presenting Cells And Their Use In Cell Therapies App 20120115223 - Cai; Zeling ; et al.	2012-05-10
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease Grant 8,133,728 - Cai , et al. March 13, 2	2012-03-13
IgE antigenic peptides Grant 8,133,972 - Cai , et al. March 13, 2	2012-03-13
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease Grant 8,133,726 - Cai , et al. March 13, 2	2012-03-13
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies Grant 8,124,408 - Cai , et al. February 28, 2	2012-02-28
Identification Of Antigenic Peptides From Multiple Myeloma Cells App 20120046645 - CAI; ZELING ; et al.	2012-02-23
Identification Of Antigenic Peptides From Multiple Myeloma Cells App 20120045829 - CAI; ZELING ; et al.	2012-02-23
Identification Of Antigenic Peptides From Multiple Myeloma Cells App 20120045466 - CAI; ZELING ; et al.	2012-02-23
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease Grant 8,106,153 - Cai , et al. January 31, 2	2012-01-31
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease Grant 8,084,256 - Cai , et al. December 27, 2	2011-12-27
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease Grant 8,084,253 - Cai , et al. December 27, 2	2011-12-27
Identification of antigenic peptides from multiple myeloma cells Grant 8,075,895 - Cai , et al. December 13, 2	2011-12-13
Identification Of Antigenic Peptides From Multiple Myeloma Cells App 20110070185 - Cai; Zeling ; et al.	2011-03-24
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease App 20110065187 - Cai; Zeling ; et al.	2011-03-17
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease App 20110065186 - Cai; Zeling ; et al.	2011-03-17
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease App 20110065180 - Cai; Zeling ; et al.	2011-03-17
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease App 20110027301 - Cai; Zeling ; et al.	2011-02-03
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease App 20110021747 - Cai; Zeling ; et al.	2011-01-27
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergice Disease App 20110020309 - Cai; Zeling ; et al.	2011-01-27
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease App 20110015370 - Cai; Zeling ; et al.	2011-01-20
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease Grant 7,842,501 - Cai , et al. November 30, 2	2010-11-30
Isolated CD8 .sup.+T lymphocytes specifically cytotoxic for a disease causing target cell Grant 7,811,816 - Cai , et al. October 12, 2	2010-10-12
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease App 20090202506 - Cai; Zeling ; et al.	2009-08-13
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies App 20090017000 - Cai; Zeling ; et al.	2009-01-15
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease App 20070098734 - Cai; Zeling ; et al.	2007-05-03
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease App 20030170212 - Cai, Zeling ; et al.	2003-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.